View Older Stories View More Recent Stories

Nov 13, 2018 04:05PM EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 13, 2018 06:56AM Eyegate Pharma (EYEG) Highlights Positive Results in Second PRK Study
Nov 13, 2018 06:55AM Eyegate Pharma (EYEG) Reports Positive Results in Punctate Epitheliopathy Study
Nov 13, 2018 06:55AM EyeGate Pharma Announces Positive Results in Second PRK Study
Nov 13, 2018 06:55AM EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study
Nov 13, 2018 06:55AM EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study
Nov 13, 2018 06:55AM EyeGate Pharma Announces Positive Results in Second PRK Study
Oct 2, 2018 06:55AM EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
Oct 2, 2018 06:55AM EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
Sep 25, 2018 06:55AM EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
Sep 25, 2018 06:55AM EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
Sep 24, 2018 06:55AM EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
Sep 24, 2018 06:55AM EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
Sep 4, 2018 08:35AM Eyegate Pharma (EYEG) Reports Randomization of First Patients in Study for Punctate Epitheliopathies
Sep 4, 2018 08:31AM Eyegate Pharma (EYEG) Reports Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis
Sep 4, 2018 08:31AM EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies
Sep 4, 2018 08:31AM EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies
Sep 4, 2018 08:30AM EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis
Sep 4, 2018 08:30AM EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis
Aug 29, 2018 08:30AM EyeGate Pharmaceuticals Announces Participation at the H.C. Wainwright 20th Annual Global Investment Conference
Aug 29, 2018 08:30AM EyeGate Pharmaceuticals Announces Participation at the H.C. Wainwright 20th Annual Global Investment Conference
Aug 20, 2018 08:34AM Eyegate Pharma (EYEG) Reports First Patient Enrollment in PRK Pilot Study
Aug 20, 2018 08:30AM EyeGate Announces Enrollment of First Patient in PRK Pilot Study
Aug 20, 2018 08:30AM EyeGate Announces Enrollment of First Patient in PRK Pilot Study
Aug 7, 2018 08:43AM Eyegate Pharma (EYEG) Appoints Peter Greenleaf to Board
Aug 7, 2018 08:30AM EyeGate Pharmaceuticals Announces New Board Member, Peter Greenleaf
Aug 7, 2018 08:30AM EyeGate Pharmaceuticals Announces New Board Member, Peter Greenleaf
Aug 3, 2018 08:30AM EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Aug 3, 2018 08:30AM EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Jul 24, 2018 08:32AM Eyegate Pharma (EYEG) Granted FDA Approval of Two IDE Submissions for Ocular Bandage Gel
Jul 24, 2018 08:30AM EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
Jul 24, 2018 08:30AM EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
Jun 22, 2018 08:31AM Eyegate Pharma (EYEG) Says it Addressed Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
Jun 22, 2018 08:30AM EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
Jun 22, 2018 08:30AM EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
May 30, 2018 08:30AM EyeGate Files Supplement to Investigational Device Exemption to Commence Study in Punctate Epitheliopathy using the EyeGate Ocular Bandage Gel
May 30, 2018 08:30AM EyeGate Files Supplement to Investigational Device Exemption to Commence Study in Punctate Epitheliopathy using the EyeGate Ocular Bandage Gel
May 22, 2018 08:38AM Eyegate Pharma (EYEG) Responds to FDA Review, Addressing 3 of 4 Action Items in Second Amendment with Submission of Investigational Device Exemption
May 22, 2018 08:30AM EyeGate Addresses Majority of FDA’s Action Items with Submission of Investigational Device Exemption Amendment for Ocular Bandage Gel
May 22, 2018 08:30AM EyeGate Addresses Majority of FDA’s Action Items with Submission of Investigational Device Exemption Amendment for Ocular Bandage Gel
May 16, 2018 04:30PM EyeGate Pharmaceuticals Announces New Board Member, Steven Boyd
May 16, 2018 04:30PM EyeGate Pharmaceuticals Announces New Board Member, Steven Boyd
May 11, 2018 08:30AM EyeGate Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
May 11, 2018 08:30AM EyeGate Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
Apr 11, 2018 08:32AM Eyegate Pharma (EYEG) Secures New Patent for Iontophoretic Contact Lens Technology
Apr 11, 2018 08:30AM EyeGate Issued New Patent for Iontophoretic Contact Lens Technology
Apr 9, 2018 08:34AM Eyegate Pharma (EYEG) Announces FDA Feedback on IDE Amendment for Second Pilot Study of Ocular Bandage Gel
Apr 9, 2018 08:30AM EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Apr 6, 2018 08:32AM UPDATE: Eyegate Pharma (EYEG) Secures Milestone Payment for Complete Enrollment of Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior
Apr 6, 2018 08:30AM EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
View More Recent Stories View Older Stories